SASMAR Pharma Strengthens Market Position with Acquisition of Goodwin Nutrition Srl and Moringa Boost Brand
SASMAR Pharmaceuticals has announced the acquisition of Goodwin Nutrition Srl, including its well-regarded Moringa Boost brand, marking a significant step in its strategy to broaden...
New Book Offers Essential Guide for Dentists Aspiring to Open Their Own Practice
Opening a dental practice represents a significant career achievement, yet it involves navigating a myriad of challenges beyond clinical skills. Joseph A. Wineman DMD, MHA,...
flinkey Revolutionizes Ride-Hailing with Digital Vehicle Access Solution
The ride-hailing industry is witnessing a transformative shift with the introduction of flinkey’s digital vehicle access solution. Developed by WITTE:digital, this innovative technology addresses the...
Global Council for Tolerance and Peace Urges De-escalation Between Cambodia and Thailand
The Global Council for Tolerance and Peace (GCTP), under the leadership of H.E. Ahmed Aljarwan, has issued a pressing call for the de-escalation of tensions...
Nobel Laureate Prof. Pierre Agostini on the Evolution and Impact of Attosecond Science
Prof. Pierre Agostini, awarded the 2023 Nobel Prize in Physics alongside Ferenc Krausz and Anne L’Huillier, has significantly advanced our understanding of electron dynamics through...
1930 Ford Model A Hot Rod Showcases American Ingenuity at DFW Car & Toy Museum
The DFW Car & Toy Museum in Fort Worth has introduced a stunning piece of automotive history to its collection, a 1930 Ford Model A...
Best Wall Clock Expands Luxury Collection with Iconic Brand-Inspired Designs
Best Wall Clock (BWC), a leading online platform for luxury wall clocks, has recently expanded its collection to include designs inspired by renowned brands such...
Mullen Automotive Inc. Rebrands to Bollinger Innovations, Signaling Strategic Shift
Mullen Automotive Inc. (NASDAQ: MULN), a prominent electric vehicle manufacturer, is set to undergo a significant rebranding, changing its name to Bollinger Innovations, Inc. starting...
Candel Therapeutics’ CAN-2409 Receives European Orphan Designation for Pancreatic Cancer Treatment
Candel Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced that the European Medicines Agency (EMA) has granted Orphan Designation for its drug CAN-2409, aimed at...